COVID-19: FDA Expands List Of Remote Monitoring Devices That Don’t Need Premarket Notification
Executive Summary
The US agency has added gaseous-phase carbon-dioxide gas analyzers to its list of products that – during the coronavirus pandemic – will not require a new premarket notification to be marketed for remote monitoring.